Nikola P Pavletich

This inventor holds 5 USPTO granted patents. Top assignees: Takeda San Diego, Inc., Sloan-Kettering Institute for Cancer Research. Active years: 2004-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikola P Pavletich. Retrieved from https://idiyas.com/inventor/nikola-p-pavletich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 20.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 5(Granted Patents)

Company Filing History:

3 out of 53

Takeda San Diego, Inc.

patents

2 out of 519

Sloan-Kettering Institute for Cancer Research

patents

Years Active: 2004-2008

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7444273 - Crystallization of aurora/LPL1P-related kinase (2008-10-28),

2. 7326552 - Wild-type kinase domain of human Ephrin receptor A2 (EPHA2) and crystallization thereof (2008-02-05),

3. 7303892 - Crystallization of AKT3 (2007-12-04),

4. 7124068 - Crystal structure of a deacetylase and inhibitors thereof (2006-10-17),

5. 6824971 - Methods of inhibiting or enhancing the TGF&bgr;-SMAD signaling pathway (2004-11-30),

Title: The Innovative Contributions of Nikola P Pavletich

Introduction

Nikola P Pavletich is a prominent inventor based in New York, NY, known for his significant contributions to the field of biochemistry and molecular biology. With a total of five patents to his name, Pavletich has made strides in understanding and utilizing various kinases, which play crucial roles in cellular processes.

Latest Patents

Among his latest patents, Pavletich has developed methods for the crystallization of Aurora/LPL1P-related kinase. This innovation provides crystals that relate to the kinase and its various applications in research and medicine. Another notable patent involves the wild-type kinase domain of the human Ephrin receptor A2 (EPHA2), which also includes methods for crystallization and its potential uses in therapeutic contexts.

Career Highlights

Throughout his career, Nikola P Pavletich has worked with esteemed organizations such as Takeda San Diego, Inc. and the Sloan-Kettering Institute for Cancer Research. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Pavletich has collaborated with notable colleagues, including Jacek Nowakowski and Devon A Thompson, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Nikola P Pavletich's innovative work and patents reflect his dedication to advancing scientific knowledge in the field of kinases. His contributions continue to influence research and development in biochemistry and molecular biology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]